These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

903 related items for PubMed ID: 15388289

  • 1. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J, Schulteis G.
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [Abstract] [Full Text] [Related]

  • 2. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G, Morse AC, Liu J.
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [Abstract] [Full Text] [Related]

  • 3. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G, Morse AC, Liu J.
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [Abstract] [Full Text] [Related]

  • 4. Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.
    Amitai N, Liu J, Schulteis G.
    Behav Pharmacol; 2006 May; 17(3):213-22. PubMed ID: 16571999
    [Abstract] [Full Text] [Related]

  • 5. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.
    Zhang Z, Schulteis G.
    Pharmacol Biochem Behav; 2008 May; 89(3):392-403. PubMed ID: 18308382
    [Abstract] [Full Text] [Related]

  • 6. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR, Jones BC, Schulteis G.
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [Abstract] [Full Text] [Related]

  • 7. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L, Cador M, Zorrilla EP, Koob GF.
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [Abstract] [Full Text] [Related]

  • 8. Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.
    Schulteis G, Chiang D, Archer C.
    Pharmacol Biochem Behav; 2009 Mar; 92(1):157-63. PubMed ID: 19061911
    [Abstract] [Full Text] [Related]

  • 9. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK, Bhateja P, Singh TG, Singh N.
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [Abstract] [Full Text] [Related]

  • 10. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M, Timár J, Riba P, Friedmann T, Király KP, Gyarmati S, Al-Khrasani M, Fürst S.
    Brain Res Bull; 2011 Jan 15; 84(1):53-60. PubMed ID: 20934489
    [Abstract] [Full Text] [Related]

  • 11. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.
    Holtz NA, Radke AK, Zlebnik NE, Harris AC, Carroll ME.
    Brain Res; 2015 Mar 30; 1602():119-26. PubMed ID: 25582876
    [Abstract] [Full Text] [Related]

  • 12. Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats.
    Schulteis G, Liu J.
    Alcohol; 2006 May 30; 39(1):21-8. PubMed ID: 16938626
    [Abstract] [Full Text] [Related]

  • 13. Severe deficit in brain reward function associated with fentanyl withdrawal in rats.
    Bruijnzeel AW, Lewis B, Bajpai LK, Morey TE, Dennis DM, Gold M.
    Biol Psychiatry; 2006 Mar 01; 59(5):477-80. PubMed ID: 16169528
    [Abstract] [Full Text] [Related]

  • 14. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
    Schulteis G, Heyser CJ, Koob GF.
    Psychopharmacology (Berl); 1997 Jan 01; 129(1):56-65. PubMed ID: 9122364
    [Abstract] [Full Text] [Related]

  • 15. Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.
    Wiebelhaus JM, Walentiny DM, Beardsley PM.
    J Pharmacol Exp Ther; 2016 Jan 01; 356(1):43-52. PubMed ID: 26491062
    [Abstract] [Full Text] [Related]

  • 16. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov 01; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

  • 17. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
    Dong Z, Han H, Cao J, Xu L.
    Hippocampus; 2010 Feb 01; 20(2):335-43. PubMed ID: 19437411
    [Abstract] [Full Text] [Related]

  • 18. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats.
    Ahmadi-Soleimani SM, Ghaemi-Jandabi M, Azizi H, Semnanian S.
    Neurosci Lett; 2014 Jan 13; 558():62-6. PubMed ID: 24211689
    [Abstract] [Full Text] [Related]

  • 19. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex.
    Diaz SL, Kemmling AK, Bonavita CD, Rubio MC, Balerio GN.
    Synapse; 2004 Oct 13; 54(1):24-9. PubMed ID: 15300881
    [Abstract] [Full Text] [Related]

  • 20. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A, Khani A, Naderi N, Alizadeh AM, Motamedi F.
    Pharmacol Biochem Behav; 2008 Feb 13; 88(4):385-92. PubMed ID: 17915302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.